|
Lopez-Galvez R, Rivera-Caravaca JM, Mandaglio-Collados D, Ruiz-Alcaraz AJ, Lahoz-Tornos A, Hernandez-Romero D, Orenes-Pinero E, Ramos-Bratos MP, Martinez CM, Carpes M, Arribas-Leal JM, Canovas S, Lip GYH, Marin F. Endothelial activation, Cell-Cell Interactions, and Inflammatory Pathways in Postoperative Atrial Fibrillation Following Cardiac Surgery. Biomed J. 2024 Nov 25:100821. doi: 10.1016/j.bj.2024.100821. Online ahead of print. PubMed PMID: 39603594.
AÑO: 2024; IF: 4.1
|
39603594
|
Proietti R, Rivera-Caravaca JM, Harrison SL, Buckley BJR, Lopez-Galvez R, Marin F, Fairbairn T, Madine J, Akhtar R, Underhill P, Field M, Lip GYH. Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis. Intern Emerg Med. 2023 Mar;18(2):423-428. doi: 10.1007/s11739-022-03184-6. Epub 2023 Jan 14. PubMed PMID: 36640228; PubMed Central PMCID: PMC10017617.
AÑO: 2023; IF: 3.2
|
|
Porlan MV, Tello-Montoliu A, Lopez-Garcia C, Gil-Perez P, Quintana-Giner M, Lopez-Galvez R, Rivera-Caravaca JM, Marin F, Figal DP. Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients. Int J Cardiol Heart Vasc. 2023 Mar 27;46:101195. doi: 10.1016/j.ijcha.2023.101195. eCollection 2023 Jun. PubMed PMID: 37032997; PubMed Central PMCID: PMC10074586.
AÑO: 2023; IF: 2.9
|
|
Proietti R, Rivera-Caravaca JM, Lopez-Galvez R, Harrison SL, Buckley BJR, Marin F, Underhill P, Shantsila E, Shantsila A, Davies R, Lane DA, Lip GYH. Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis. Clin Cardiol. 2023 Jun;46(6):656-662. doi: 10.1002/clc.24006. Epub 2023 Apr 10. PubMed PMID: 37038622; PubMed Central PMCID: PMC10270263.
AÑO: 2023; IF: 2.4
|
|
Proietti R, Rivera-Caravaca JM, Lopez-Galvez R, Harrison SL, Marin F, Underhill P, Shantsila E, McDowell G, Vinciguerra M, Davies R, Giebel C, Lane DA, Lip GYH. Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. J Clin Med. 2023 Apr 11;12(8):2814. doi: 10.3390/jcm12082814. PubMed PMID: 37109151; PubMed Central PMCID: PMC10142574.
AÑO: 2023; IF: 3.0
|